Free CME-Certified, On-Demand Webcast: Optimizing Interventional Pharmacology for PCI in ACS: Applying the Evidence to Real-World Settings
COLUMBIA, Md., June 8 /PRNewswire/ — Schering-Plough and INNOVIA Education Institute, LLC, present a free CME-certified, on-demand webcast, “OPTIMZING INTERVENTIONAL PHARMACOLOGY FOR PCI IN ACS: APPLYING THE EVIDENCE TO REAL-WORLD SETTINGS.” Recorded during the Society for Cardiovascular Angiography and Interventions (SCAI) 30th Annual Scientific Sessions in Orlando, Florida, this highly dynamic, case-based symposium provides interventional cardiologists and other clinicians with detailed information and lively discussion on pharmacoinvasive therapies to improve the outcomes of patients undergoing PCI.
FACULTY: — James J. Ferguson, III, MD (Program Chair), Texas Medical Center’s Texas Heart Institute — Lisa K. Jennings, PhD, University of Tennessee Health Science Center — Neal S. Kleiman, MD, The Methodist DeBakey Heart Center and Weill Medical College at Cornell University WHERE: http://www.iian.ibeam.com/events/mult001/21914
HOW: Live over the Internet-simply log on to the above web site at your convenience. Available for download for one year, the CME-certified webcast runs approximately 1 hour and 30 minutes.
CREDIT HOURS: INNOVIA Education Institute designates this educational activity for a maximum of 1.5 AMA Category 1 Credit(s)(TM). Physicians should only claim credit commensurate with the extent of their participation in the activity.
LEARNING OBJECTIVES Upon completion of this activity, participants should be able to: — Define a treatment algorithm integrating percutaneous coronary intervention (PCI) and pharmacologic interventions intended to optimize interventional strategies in acute coronary syndromes (ACS) — Tailor interventional strategies for ACS according to patient presentation and facility capabilities, with an emphasis on timely procedures — Improve utilization of pharmacoinvasive therapy for the treatment of ACS patients, based on treatment guidelines and emerging evidence — Apply the latest data to real-world settings of modern-day interventional practice PROGRAM OVERVIEW
Each year, in the United States, more than 5.3 million patients present to the emergency department with chest discomfort and related symptoms of ST elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina (UA). Continued research to guide treatment decisions and strategies, including percutaneous coronary intervention (PCI), is crucial for these acute coronary syndrome (ACS) patients.
This symposium will examine ongoing clinical trials and available data for Optimizing Interventional Pharmacology for PCI in ACS. The faculty will address patient management challenges presented by differing organizational protocols and discuss options for the interventional clinician. Using an innovative case-based approach, participants will consider the implications of various factors, including initial clinical presentation of ACS, the facility’s capability to perform PCI, time delays from symptom onset to reperfusion, and the risk of adverse outcomes. Join us online!
ABOUT INNOVIA EDUCATION INSTITUTE
INNOVIA Education Institute, LLC, the coordinator of this educational activity, has been an accredited provider of continuing medical education (CME) for physicians since 1988. Headquartered in Columbia, MD, INNOVIA Education Institute is dedicated to independent, science-based communications for health care product manufacturers and quality professional education with the goal of providing information to health care providers that ultimately improves patient care. Find out more information about INNOVIA at http://innoviaeducation.com/.
CONTACT INFORMATION
For more information about the program, please contact Carolyn Samuel at (410) 312-3628 or csamuel@innoviaeducation.com
INNOVIA Education Institute
CONTACT: Carolyn Samuel of INNOVIA Education Institute, +1-410-312-3628,or csamuel@innoviaeducation.com
Web site: http://innoviaeducation.com/